chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye swelling, Headache, Loss of personal independence in daily activities, Swelling
Clinical narrative: Two weeks after the second the dose, he woke up to a swollen eye. No redness, itching or infection involved just swelling. The swelling went away after 4 days and the other eye swelled up.  Even though he wears glasses permanently he has never had issues with his eyes other than vision impairment. Now, having one eye swell up from time to time worries me because like I said he has vision problems and having one eye shut down makes it difficult to do everyday tasks as it is follwed by a headache. Other family members are having the same issue after their third dose but they don't feel comfortable reporting it even though they share the same opinion about an unbearable migraine like headache.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Pain, Pain in extremity, Rash, Rash papular
Clinical narrative: Patient reported having a large raised rash on left arm after vaccination that was also painful. 4  months after vaccination patient is still complaining of severe pain in the arm and is unable to raise her arm beyond her shoulder without experiencing severe pain. She is undergoing further medical evaluation in which doctor is suggesting potential surgery for rotator cuff issue stemming from vaccination.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Asthma, Asthma exercise induced, Chest discomfort, Dyspnoea, Echocardiogram normal
Clinical narrative: Developed exercised induced asthma. After running 2 laps at relaxed pace (about 4 minutes depending on air quality and temperature) start experiencing shortness of breath, tightness of chest, fatigue, excess phlegm in lungs, and audible wheezing upon exhale. Never had asthma before, methacholine test concluded I am asthmatic now.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Echoencephalogram normal, Fatigue, Productive cough, Pulmonary function challenge test abnormal, Spirometry normal
Clinical narrative: Developed exercised induced asthma. After running 2 laps at relaxed pace (about 4 minutes depending on air quality and temperature) start experiencing shortness of breath, tightness of chest, fatigue, excess phlegm in lungs, and audible wheezing upon exhale. Never had asthma before, methacholine test concluded I am asthmatic now.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Developed exercised induced asthma. After running 2 laps at relaxed pace (about 4 minutes depending on air quality and temperature) start experiencing shortness of breath, tightness of chest, fatigue, excess phlegm in lungs, and audible wheezing upon exhale. Never had asthma before, methacholine test concluded I am asthmatic now.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Chest X-ray, Echocardiogram, Full blood count, Heart rate abnormal
Clinical narrative: SVT 170s-Adenosine x1-converted back to ST 130S Palpitation/tachycardia-magnesium and phosphorous IV medication administered; Cardizem oral administered-HR controlled
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Palpitations, Supraventricular tachycardia, Tachycardia, Troponin
Clinical narrative: SVT 170s-Adenosine x1-converted back to ST 130S Palpitation/tachycardia-magnesium and phosphorous IV medication administered; Cardizem oral administered-HR controlled
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical urticaria, Pruritus, Rash
Clinical narrative: About a week and a half after receiving my Covid booster I woke up with a rash and extremely itchy. Went to a dermatologist and learned is it dermatographia. Was told to take allergy pills but have no relieve. When I googled this I found there are hundreds of other people who had this happen after receiving their Moderna booster.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pallor
Clinical narrative: patient's face went pale. patient reported light headedness and dizziness. Patient's face and upper extremities were pale. Gave patient water and lollipop and had him sit for 5 to 10 minutes. Paramedics arrived in 10 minutes and checked blood pressure. Patient felt better and left after 10 minutes.
Sex: F
Vaccine: COVID19
Symptoms: Limb injury, Product administered at inappropriate site
Clinical narrative: Moderna covid 19 vaccine, pt claimed she got the shot too high in the arm so it injured her arm. the patient came to get her booster covid 19 vaccine, and the patient claimed the immunizer administered the shot to high in the arm.
Sex: F
Vaccine: COVID19
Symptoms: Biopsy kidney abnormal, Fatigue, Hypertension, IgA nephropathy, Immune system disorder
Clinical narrative: 15-year-old female with history of C3 glomerulonephritis since 2019 received Pfizer Covid vaccination #3 (immunosuppressed patient) in August 2021 associated with fever, hypertension, fatigue. Her C3 GN was well controlled prior to Covid vaccination, on mycophenolate. Subsequently she developed high-grade proteinuria leading to kidney biopsy in December 2021 which demonstrated concern of IgA nephropathy on background of C3 glomerulonephritis. The new IgA nephropathy findings were felt to most likely relate to immune stimulus following Covid vaccination.
Sex: F
Vaccine: COVID19
Symptoms: Proteinuria, Pyrexia, Urine protein/creatinine ratio, Vaccination complication
Clinical narrative: 15-year-old female with history of C3 glomerulonephritis since 2019 received Pfizer Covid vaccination #3 (immunosuppressed patient) in August 2021 associated with fever, hypertension, fatigue. Her C3 GN was well controlled prior to Covid vaccination, on mycophenolate. Subsequently she developed high-grade proteinuria leading to kidney biopsy in December 2021 which demonstrated concern of IgA nephropathy on background of C3 glomerulonephritis. The new IgA nephropathy findings were felt to most likely relate to immune stimulus following Covid vaccination.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram normal, Haematuria, Protein urine present, Thrombosis
Clinical narrative: Hematuria with clot. Covid booster was given on 1/27/22 Health young adult experienced sudden frank hematuria with large clot. This required ER visit. Urinalysis also positive for protein
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: Hematuria with clot. Covid booster was given on 1/27/22 Health young adult experienced sudden frank hematuria with large clot. This required ER visit. Urinalysis also positive for protein
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Immunocompromised patient presented for 4th vaccination injection. Patient received full vaccine dose instead of booster dose (.25ml)
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient present for booster shot and received Moderna. Patient should have been given Pfizer since the patient was <18 years old.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given expired vaccine ? dose expires 12h after 1st puncture; dose was given 2 days after 1st puncture
Sex: F
Vaccine: VARZOS
Symptoms: Malaise, Nucleic acid test, Pain in extremity, SARS-CoV-2 test negative, Vaccination complication
Clinical narrative: Received shingles vaccine from my doctor at his office on 02/12/2022. By Monday, 02/14/2022, I developed what looks like "covid toe", an extremely painful condition. Lab performed a Covid PCR test which has come back negative. No Covid. Shingrix vaccine made me very sick. I'm in a lot of pain in my left foot. I have photos of my "covid toe" which I will upload as well the lab test results for covid. I stupidly listened to my doctor's advice.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Erectile dysfunction, Headache, Injection site pain, Mobility decreased
Clinical narrative: Narrative: Patient would like to report the side effects he experienced after receiving the MODERNA vaccine 04/15/2021. He reports 20 minutes after receiving the second moderna dose he had an extreme headache. Then he was bed ridden for 3 days with body aches, and soreness at the injection site. He also had erectile dysfunction for 2 weeks along with intermittent burning sensations throughout his body. He reports he had covid prior to getting vaccinated and his symptoms were near as bad then with the vaccine. Patient reports COVID positive Nov 2020. Symptoms: Symptoms: 1. Headache
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Narrative: Patient would like to report the side effects he experienced after receiving the MODERNA vaccine 04/15/2021. He reports 20 minutes after receiving the second moderna dose he had an extreme headache. Then he was bed ridden for 3 days with body aches, and soreness at the injection site. He also had erectile dysfunction for 2 weeks along with intermittent burning sensations throughout his body. He reports he had covid prior to getting vaccinated and his symptoms were near as bad then with the vaccine. Patient reports COVID positive Nov 2020. Symptoms: Symptoms: 1. Headache
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Vomiting
Clinical narrative: Headache, NauseaVomiting, pain Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Nausea, Vomiting
Clinical narrative: NauseaVomiting Nausea and weakness started about 10 minutes post vaccination Narrative:  Employee sent to ER for firther evaluation
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Palpitations
Clinical narrative: Dizziness, Palpitations, fatigue, brain fog Narrative:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling cold, Headache, Injection site pain
Clinical narrative: Pain at injection site 2/22/21 at 11pm-2/13/21 at 6am Fatigue 2/11/21 at 5:30p through 8:30p on 2/12/21 Headache 2/11/21 starting at 1:30p through 2/13/21 at 6am Nausea intermittently on 2/11/21 at 1:30p through 2/12/21 at 8:30p Body chills intermittently 2/11/21 at 11:30p through 2/12/21 8:30p Joint pain intermittently 2/12/21 at 4:00a-2/12/21 at 8:30p
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Pain at injection site 2/22/21 at 11pm-2/13/21 at 6am Fatigue 2/11/21 at 5:30p through 8:30p on 2/12/21 Headache 2/11/21 starting at 1:30p through 2/13/21 at 6am Nausea intermittently on 2/11/21 at 1:30p through 2/12/21 at 8:30p Body chills intermittently 2/11/21 at 11:30p through 2/12/21 8:30p Joint pain intermittently 2/12/21 at 4:00a-2/12/21 at 8:30p
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Client was given pediatric dose of Pfizer Covid vaccine instead of the adult formulation
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Headache, Muscle twitching
Clinical narrative: 1st vaccine - hour after vaccine administered, started having (L) eye/facial twitching and headache -> went away after about 4 days  2nd vaccine - same thing
Age: 72.0
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: 2-17-22 Patient called to report redness and itching at Left deltoid area. Swollen to "size of small plate."
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Energy increased, Nausea, Paraesthesia, Taste disorder
Clinical narrative: Nausea; Tingly sensation in her tongue; Metallic taste; Palette; After the first dose she felt very energized; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nausea"; PARAESTHESIA (non-serious), outcome "unknown", described as "Tingly sensation in her tongue"; DYSGEUSIA (non-serious), outcome "unknown", described as "Metallic taste"; TASTE DISORDER (non-serious), outcome "unknown", described as "Palette"; ENERGY INCREASED (non-serious), outcome "unknown", described as "After the first dose she felt very energized".  Additional information: After the 1st dose, patient had a mild reaction included nausea, tingly sensation in her tongue and palette, metallic taste. After the first dose she felt very energized.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Illness
Clinical narrative: nausea; headache; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 10Mar2021 12:30 (Lot number: EN6205) at the age of 80 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Pfizer Covid-19 Vaccine Details:, Dose: 1st, Date/time: 17Feb2021 01:45 PM, Anatomical location: Right Arm, Route of administration: intramuscular, Lot number: EL9266), administration date: 17Feb2021, when the patient was 80 years old, for Covid-19 immunization, reaction(s): "Nausea", "deep Sleep", "Violent headache", "vivid  dreams", "Overheated", "sore body", "Upchuck", "Loss appetite"; Bnt162b2, administration date: 17Feb2021, for Covid-19 immunization, reaction(s): "qvt pain"; Flu vaccine, reaction(s): "I put up weight". The following information was reported: NAUSEA (non-serious) with onset 10Mar2021 12:45, outcome "recovered" (13Mar2021 00:45), described as "nausea"; HEADACHE (non-serious) with onset 10Mar2021 12:45, outcome "recovered" (13Mar2021 00:45), described as "headache"; PAIN IN EXTREMITY (non-serious) with onset 10Mar2021 12:45, outcome "recovered" (13Mar2021 00:45), described as "sore arm". Therapeutic measures were taken as a result of nausea, headache.  No follow-up attempts are possible. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: nausea; headache; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 10Mar2021 12:30 (Lot number: EN6205) at the age of 80 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Pfizer Covid-19 Vaccine Details:, Dose: 1st, Date/time: 17Feb2021 01:45 PM, Anatomical location: Right Arm, Route of administration: intramuscular, Lot number: EL9266), administration date: 17Feb2021, when the patient was 80 years old, for Covid-19 immunization, reaction(s): "Nausea", "deep Sleep", "Violent headache", "vivid  dreams", "Overheated", "sore body", "Upchuck", "Loss appetite"; Bnt162b2, administration date: 17Feb2021, for Covid-19 immunization, reaction(s): "qvt pain"; Flu vaccine, reaction(s): "I put up weight". The following information was reported: NAUSEA (non-serious) with onset 10Mar2021 12:45, outcome "recovered" (13Mar2021 00:45), described as "nausea"; HEADACHE (non-serious) with onset 10Mar2021 12:45, outcome "recovered" (13Mar2021 00:45), described as "headache"; PAIN IN EXTREMITY (non-serious) with onset 10Mar2021 12:45, outcome "recovered" (13Mar2021 00:45), described as "sore arm". Therapeutic measures were taken as a result of nausea, headache.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspepsia, Headache
Clinical narrative: headache; chills; Heartburn starting at 48 hr post vaccination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Feb2021 (Lot number: EL3247) at the age of 41 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PROBIOTICS (ongoing); VITAMIN D NOS (ongoing). Vaccination history included: Bnt162b2 (Dose 1, single), administration date: 28Jan2021, when the patient was 41 years old, for COVID-19 immunization. The following information was reported: DYSPEPSIA (non-serious) with onset 20Feb2021 18:00, outcome "recovered", described as "Heartburn starting at 48 hr post vaccination"; HEADACHE (non-serious), outcome "recovered", described as "headache"; CHILLS (non-serious), outcome "recovered", described as "chills". Therapeutic measures were taken as a result of dyspepsia. Therapeutic measures were not taken as a result of headache, chills. Additional information: Heartburn starting at 48hr post vaccination. Significant heartburn feeling. No dietary changes at the time of occurrence. No history of heartburn. Headache. Chills. No admission to hospital due to the events. Patient fine now. No issues of heartburn Since.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: had a lot of pain just 30 minutes after the second shot; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 (Lot number: ER733, Expiration Date: 31Jul2021) at the age of 65 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (I took Pfizer COVID vaccine, the first shot on (10Mar2021) and I have some weird side effects and I need to report it., LOT# for first shot: EN6198, Expiration date of first shot: 30Jun2021, First shot was in right arm , When probed for adverse events, Nurse stated, "I have severe lower back pain with first shot and I took prednisone (Treatment) for it and on Mar14, I developed weird rash and neck pain near my clavicle bone.), administration date: 10Mar2021, for COVID-19 immunisation, reaction(s): "lower back pain", "rash", "neck pain near my clavicle bone". The following information was reported: PAIN (non-serious) with onset 29Mar2021, outcome "unknown", described as "had a lot of pain just 30 minutes after the second shot".  Additional information: After the second shot, 30 minutes past the second shot, patient had a lot of pain just 30 minutes after the second shot, however there was no allergic reaction to it.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: worsening of my existing tinnitus/louder in the right ear; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Mar2021 10:45 (Lot number: EN6204) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "GERD" (unspecified if ongoing); "Sleep apnea" (unspecified if ongoing); "obesity" (unspecified if ongoing); "known allergies: Pollens only" (unspecified if ongoing), notes: Pollens only. Concomitant medication(s) included: FAMOTIDINE; CETIRIZINE; GLUCOSAMINE/CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE HYDROCHLORIDE]. The following information was reported: TINNITUS (non-serious) with onset 24Mar2021, outcome "not recovered", described as "worsening of my existing tinnitus/louder in the right ear". The event "worsening of my existing tinnitus/louder in the right ear" was evaluated at the physician office visit. Therapeutic measures were taken as a result of tinnitus included Nasal Steroids.  Additional information: The patient experienced a worsening of existing tinnitus that has improved somewhat but still not back to baseline level four weeks after the first dose, and was louder in the right ear, where it was pulsatile. After second dose the tinnitus did not worsen, but I had a few bouts of vertigo within a week of second dose (16Apr). The patient had not diagnosed with COVID-19 prior to vaccination and was not COVID-19 since vaccination. Facility type vaccine: Hospital. No other vaccine was administered in four weeks.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Headache, Pain
Clinical narrative: his blood pressure elevated; Headache; soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLOOD PRESSURE INCREASED (non-serious), outcome "unknown", described as "his blood pressure elevated"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; PAIN (non-serious), outcome "unknown", described as "soreness". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient received first dose and is scheduled for second dose in about 2 weeks. He had a reaction to first dose.20 minutes after receiving first dose his blood pressure elevated. It went down eventually. He had a headache and soreness. He is scheduled for an MRI test next week. The enquired if MRI test will interfere with his health and vaccine in any way. He wanted to know if he should still get second dose.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Ecchymosis, Peripheral swelling, SARS-CoV-2 test
Clinical narrative: her big toe, on the right foot, swelled up and was black and blue, totally discolored.; her big toe, on the right foot, swelled up and was black and blue, totally discolored.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Batch/Lot number: unknown) at the age of 55 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), ECCHYMOSIS (non-serious) all with onset Apr2021, outcome "unknown" and all described as "her big toe, on the right foot, swelled up and was black and blue, totally discolored.". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient was calling about the Pfizer Covid 19 vaccine. Patient described her side effect as something rare. Patient stated 3 days after the first dose, she (Patient) noticed on her big toe, of the right foot, it was swollen, and was black and blue, totally discolored. She hadn't injured her foot at all.  Patient stated she did go to the urgent care and they looked at her toe and the provider at the urgent care said he hadn't heard of that type of reaction. Patient told they took pictures of her toe at the urgent care, but they didn't gave her any advice for what to do next before she gets the second vaccine.  Patient declined to fill out the safety report and asked if that was a reported side effect, so that she could decide where to go from there. Patient notified that Medical Information and/or Pfizer was unable to provide medical advice but they might had resources to help answer some questions. Patient took a covid test and was tested negative. Reporter seriousness for all events were reported as unspecified.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Fatigue, Pain
Clinical narrative: Chronic fatigue; Body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Lot number: EW0150) at the age of 51 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ATORVASTATIN; MONTELUKAST; XYZAL; SERTRALINE HCL; CELECOXIB; ESTRADIOL; VITAMIN D [VITAMIN D NOS]; LOSARTAN; SYNTHROID. The following information was reported: FATIGUE (non-serious) with onset 02Apr2021, outcome "not recovered", described as "Chronic fatigue"; PAIN (non-serious) with onset 02Apr2021, outcome "not recovered", described as "Body aches". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fatigue, pain.  Additional Information: Patient took Xyzal over the counter. Patient uses Estradiol patches. Patient didn't know many 'mg' of Synthroid she was taking. It may be 100. Patient history and investigation assessment was reported as Yes. Patient stated that she did report adverse side effect from Pfizer vaccine to " (not clarified the name) online, it happen to see this number of her paperwork and she thought maybe she should report it. Event start date is reported as April 2nd. She don't have the expiration date. The date product was given on was 01Apr2021. Patient takes lots of other medication for other symptoms. Patient did lab work, she had lots of Blood work done. Reporter stated that the events were still persisting. Patient received Ibuprofen 800mg as treatment and drank fluids. Patient reported that there was a product complaint. Events were still persisting.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: She started getting dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 29Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "She started getting dizzy".  Additional details: Reporter is veterinarian who received her 1st dose of the Pfizer COVID Vaccine on 29Mar2021 and after 4 hours, she started getting dizzy. She mentioned that it lasted till the next day and went away and she had no problems since then. She is asking if there would be any problems with her taking her 2nd dose. She mentioned that she made VAERS report on there where was a comment there that if she experiences any of the listed side effects, then it is not advised to take the 2nd dose. She is wanting to confirm if this is true. Response: Provided disclaimer, read, referred to HCP.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Hypoaesthesia, Investigation, Magnetic resonance imaging head, Magnetic resonance imaging spinal
Clinical narrative: I lost all sensation in my arms and in my legs; numbness and tingling in my arms and in my legs; numbness and tingling in my arms and in my legs; Paresthesia; Neurological side effects; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administration date 12Apr2021 (Batch/Lot number: unknown) at the age of 36 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: SENSORY LOSS (non-serious) with onset 12Apr2021, outcome "not recovered", described as "I lost all sensation in my arms and in my legs"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 12Apr2021, outcome "not recovered" and all described as "numbness and tingling in my arms and in my legs"; PARAESTHESIA (non-serious) with onset 12Apr2021, outcome "not recovered", described as "Paresthesia"; NEUROLOGICAL SYMPTOM (non-serious) with onset 12Apr2021, outcome "not recovered", described as "Neurological side effects". The events "i lost all sensation in my arms and in my legs", "numbness and tingling in my arms and in my legs", "numbness and tingling in my arms and in my legs", "paresthesia" and "neurological side effects" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Consumer stated, she had some adverse side effects that she experienced after she received first dose of the Pfizer vaccine on the last Monday 12Apr2021 and 5 minutes after receiving the shot she lost all sensation in arms and in legs, so had numbness and tingling and she was in and out of ER all last week and she was experiencing numbness and tingling in arms and in legs. When paraphrased the above concern, she stated, It was numbness and tingling, it's the way she described as, it also known medically Paresthesia. Consumer stated, Is someone following up with me. Does Pfizer offer because of the side effects and she went to the 3 ER doctors and internal medicine doctor's neurologist and all of these, this is all after receiving the Pfizer vaccine, does Pfizer offer any medical bill coverage or anything like that because she was experiencing expensive medical bills after this vaccine, she want to medical bills to be covered. She would like to cover her medical bills because it all happens after the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Neurological symptom, Paraesthesia, Sensory loss
Clinical narrative: I lost all sensation in my arms and in my legs; numbness and tingling in my arms and in my legs; numbness and tingling in my arms and in my legs; Paresthesia; Neurological side effects; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administration date 12Apr2021 (Batch/Lot number: unknown) at the age of 36 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: SENSORY LOSS (non-serious) with onset 12Apr2021, outcome "not recovered", described as "I lost all sensation in my arms and in my legs"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 12Apr2021, outcome "not recovered" and all described as "numbness and tingling in my arms and in my legs"; PARAESTHESIA (non-serious) with onset 12Apr2021, outcome "not recovered", described as "Paresthesia"; NEUROLOGICAL SYMPTOM (non-serious) with onset 12Apr2021, outcome "not recovered", described as "Neurological side effects". The events "i lost all sensation in my arms and in my legs", "numbness and tingling in my arms and in my legs", "numbness and tingling in my arms and in my legs", "paresthesia" and "neurological side effects" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Consumer stated, she had some adverse side effects that she experienced after she received first dose of the Pfizer vaccine on the last Monday 12Apr2021 and 5 minutes after receiving the shot she lost all sensation in arms and in legs, so had numbness and tingling and she was in and out of ER all last week and she was experiencing numbness and tingling in arms and in legs. When paraphrased the above concern, she stated, It was numbness and tingling, it's the way she described as, it also known medically Paresthesia. Consumer stated, Is someone following up with me. Does Pfizer offer because of the side effects and she went to the 3 ER doctors and internal medicine doctor's neurologist and all of these, this is all after receiving the Pfizer vaccine, does Pfizer offer any medical bill coverage or anything like that because she was experiencing expensive medical bills after this vaccine, she want to medical bills to be covered. She would like to cover her medical bills because it all happens after the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood iron, Blood iron decreased, Blood test, Colonoscopy, Endoscopy
Clinical narrative: decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; RBC size variation increased; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from medical information team. The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administration date 29Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SERUM FERRITIN DECREASED (non-serious), BLOOD IRON DECREASED (non-serious), HAEMOGLOBIN DECREASED (non-serious), HAEMATOCRIT DECREASED (non-serious) all with onset 16Feb2021, outcome "unknown" and all described as "decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit"; RED CELL DISTRIBUTION WIDTH INCREASED (non-serious) with onset 16Feb2021, outcome "unknown", described as "RBC size variation increased". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that the patient had his second dose on 21Feb2021. The reporter stated that he had lab values on 16Feb2021. The reporter stated he had a colonoscopy and endoscopy between the first and second dose that came back normal. He also stated that he would be having a capsule endoscopy on Friday. He also stated that he had immunoglobulin screenings that came back negative. The reporter stated that his last blood work in late March was unchanged, it was the ferritin thing that he was zoning in on and he reported sufficiently to VAERS.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit, Haematocrit decreased, Haemoglobin, Haemoglobin decreased, Immunoglobulins
Clinical narrative: decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; RBC size variation increased; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from medical information team. The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administration date 29Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SERUM FERRITIN DECREASED (non-serious), BLOOD IRON DECREASED (non-serious), HAEMOGLOBIN DECREASED (non-serious), HAEMATOCRIT DECREASED (non-serious) all with onset 16Feb2021, outcome "unknown" and all described as "decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit"; RED CELL DISTRIBUTION WIDTH INCREASED (non-serious) with onset 16Feb2021, outcome "unknown", described as "RBC size variation increased". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that the patient had his second dose on 21Feb2021. The reporter stated that he had lab values on 16Feb2021. The reporter stated he had a colonoscopy and endoscopy between the first and second dose that came back normal. He also stated that he would be having a capsule endoscopy on Friday. He also stated that he had immunoglobulin screenings that came back negative. The reporter stated that his last blood work in late March was unchanged, it was the ferritin thing that he was zoning in on and he reported sufficiently to VAERS.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Red cell distribution width increased, Serum ferritin, Serum ferritin decreased
Clinical narrative: decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit; RBC size variation increased; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from medical information team. The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administration date 29Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SERUM FERRITIN DECREASED (non-serious), BLOOD IRON DECREASED (non-serious), HAEMOGLOBIN DECREASED (non-serious), HAEMATOCRIT DECREASED (non-serious) all with onset 16Feb2021, outcome "unknown" and all described as "decreased ferritin levels and other saturation rates for iron serum, hemoglobin and hematocrit"; RED CELL DISTRIBUTION WIDTH INCREASED (non-serious) with onset 16Feb2021, outcome "unknown", described as "RBC size variation increased". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that the patient had his second dose on 21Feb2021. The reporter stated that he had lab values on 16Feb2021. The reporter stated he had a colonoscopy and endoscopy between the first and second dose that came back normal. He also stated that he would be having a capsule endoscopy on Friday. He also stated that he had immunoglobulin screenings that came back negative. The reporter stated that his last blood work in late March was unchanged, it was the ferritin thing that he was zoning in on and he reported sufficiently to VAERS.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Lymphadenopathy, Nausea
Clinical narrative: Swollen Lymph Nodes in left arm and neck; Stabbing Pains in Stomach; Severe Diarrhea; Nauseous; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Apr2021 13:40 (Lot number: EW0153) at the age of 55 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (ongoing), notes: Verbatim: Anxiety, States was diagnosed about 7 years ago after her husband died.; "Depression" (ongoing), notes: Verbatim: Depression, States was diagnosed about 7 years ago after her sband died.; "Back Pain" (unspecified if ongoing). Family history included: "Diabetes" (unspecified if ongoing); "sepsis" (unspecified if ongoing), notes: her mother died of sepsis. Concomitant medication(s) included: ADVIL [IBUPROFEN] taken for back pain (ongoing); XANAX taken for anxiety (ongoing). Vaccination history included: Bnt162b2 (DOSE 1, Lot Number: ER2613; Administration site: left arm.), administration date: 23Mar2021, when the patient was 55 years old, for COVID-19 Immunization. The following information was reported: ABDOMINAL PAIN UPPER (non-serious) with onset 16Apr2021, outcome "not recovered", described as "Stabbing Pains in Stomach"; DIARRHOEA (non-serious) with onset 16Apr2021, outcome "not recovered", described as "Severe Diarrhea"; NAUSEA (non-serious) with onset 16Apr2021, outcome "not recovered", described as "Nauseous"; LYMPHADENOPATHY (non-serious) with onset 17Apr2021, outcome "not recovered", described as "Swollen Lymph Nodes in left arm and neck".  Additional information: Patient stated that there were times when she could not even stand up. The pain was stabbing and consistent. Thought going to the bathroom would relieve it, but it did not. States it felt like someone was stabbing and twisting her intestines. Patient stated that she was afraid to take anything or drink anything because that makes the pain come back worse. Patient did not visit emergency room or Physician office and also did not receive any Prior Vaccinations (within 4 weeks).  Patient mentioned side effects that her son had been experiencing. Stated he had been having pain in the back of his chest and swollen lymph nodes on his neck. Report completed for son.  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Vaccination site pain
Clinical narrative: injection site soreness; muscle soreness; tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 09:30 (Lot number: EW0150) at the age of 24 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IRON; PROVERA; VITAMIN D [COLECALCIFEROL]. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Apr2021 10:30, outcome "recovered" (Apr2021), described as "injection site soreness"; MYALGIA (non-serious) with onset 05Apr2021 10:30, outcome "recovered" (Apr2021), described as "muscle soreness"; FATIGUE (non-serious) with onset 05Apr2021 10:30, outcome "recovered" (Apr2021), described as "tiredness". Therapeutic measures were not taken as a result of vaccination site pain, myalgia, fatigue.  Additional information: The patient did not receive any other vaccines within 4 week prior vaccination. The patient had not been diagnosed with COVID-19 prior vaccination and had not been tested for COVID-19 since vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Heart rate, Insomnia, Palpitations
Clinical narrative: heart palpitations/The highest recorded was 123/It then fluctuated between high 100s to low 110s; It was very uncomfortable and scary for my child; She had difficulty sleeping the night; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Apr2021 15:45 (Lot number: ER8734) at the age of 17 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Juvenile idiopathic arthritis" (unspecified if ongoing). Concomitant medication(s) included: ENBREL; METHOTREXATE. The following information was reported: PALPITATIONS (non-serious) with onset 18Apr2021 13:00, outcome "recovered" (Apr2021), described as "heart palpitations/The highest recorded was 123/It then fluctuated between high 100s to low 110s"; DISCOMFORT (non-serious) with onset 18Apr2021 13:00, outcome "recovered" (Apr2021), described as "It was very uncomfortable and scary for my child"; INSOMNIA (non-serious) with onset 18Apr2021 13:00, outcome "recovered" (Apr2021), described as "She had difficulty sleeping the night". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of palpitations, discomfort, insomnia.  Additional information: The patient did not have other vaccine in four weeks. Less than 24 hours after receiving the vaccine (at School or Student Health Clinic), patient began experiencing heart palpitations. Her normal resting heart rate was 63 (in Apr2021). The patient had a watch and was able to track her heart rate. The highest recorded was 123. It then fluctuated between high 100s to low 110s (in Apr2021). For 24 hours and then slowly came down to normal 3 days later (Apr2021). It was very uncomfortable and scary for the patient. She had difficulty sleeping the night it began. They will not be giving her the second dose. No COVID prior vaccination, and patient did not test for COVID post vaccination, no known allergies.  No follow up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: 26 hours post 2nd dose experienced Supraclavicular Lymphadenopathy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Apr2021 12:00 (Lot number: EW0172) at the age of 57 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: Other medical history: Asthma. Concomitant medication(s) included: DULERA; MONTELUKAST; AZELASTINE. Vaccination history included: Bnt162b2 (Product COVID 19, Brand: Pfizer-BioNTech , Lot number: EW0150, Lot unknown: False, Administration date: 30Mar2021, Administration time: 12:00 PM, Vaccine location: Left arm, Dose number: 1, Adverse event: 30 minutes post 1st dose an ache across my clavicle, lasted for approximately one hour.), administration date: 30Mar2021, when the patient was 57 years old, for Covid-19 Immunization, reaction(s): "ache across my clavicle". The following information was reported: LYMPHADENOPATHY (non-serious) with onset 21Apr2021 14:00, outcome "not recovered", described as "26 hours post 2nd dose experienced Supraclavicular Lymphadenopathy". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: No other vaccine was given in 4 weeks. Patient did not have covid prior to vaccination. Patient did not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.